These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24534226)

  • 1. Association between change of health care providers and pregnancy exposure to FDA category C, D and X drugs.
    Yang J; Xie R; Krewski D; Wang Y; Walker M; Cao W; Wen SW
    Chin Med J (Engl); 2014; 127(4):702-6. PubMed ID: 24534226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population.
    Yang T; Walker MC; Krewski D; Yang Q; Nimrod C; Garner P; Fraser W; Olatunbosun O; Wen SW
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):270-7. PubMed ID: 18181228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population.
    Wen SW; Yang T; Krewski D; Yang Q; Nimrod C; Garner P; Fraser W; Olatunbosun O; Walker MC
    J Perinatol; 2008 May; 28(5):324-9. PubMed ID: 18288118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to trimethoprim/sulfamethoxazole but not other FDA category C and D anti-infectives is associated with increased risks of preterm birth and low birth weight.
    Yang J; Xie RH; Krewski D; Wang YJ; Walker M; Wen SW
    Int J Infect Dis; 2011 May; 15(5):e336-41. PubMed ID: 21345707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National patterns of medication use during pregnancy.
    Lee E; Maneno MK; Smith L; Weiss SR; Zuckerman IH; Wutoh AK; Xue Z
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):537-45. PubMed ID: 16700083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence and determinants of trimethoprim/sulfamethoxazole use in pregnancy.
    Yang T; Walker MC; Krewski D; Yang Q; Garner P; Fraser W; Olatunbosun O; Nimrod C; Wen SW
    Acta Obstet Gynecol Scand; 2007; 86(11):1310-6. PubMed ID: 17963058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician characteristics and prescription drug use during pregnancy: a population-based study.
    Weng SS; Chen YH; Lin CC; Keller JJ; Wang IT; Lin HC
    Ann Epidemiol; 2013 Feb; 23(2):54-9. PubMed ID: 23218810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006).
    Daw JR; Mintzes B; Law MR; Hanley GE; Morgan SG
    Clin Ther; 2012 Jan; 34(1):239-249.e2. PubMed ID: 22169049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription drug use in pregnancy.
    Andrade SE; Gurwitz JH; Davis RL; Chan KA; Finkelstein JA; Fortman K; McPhillips H; Raebel MA; Roblin D; Smith DH; Yood MU; Morse AN; Platt R
    Am J Obstet Gynecol; 2004 Aug; 191(2):398-407. PubMed ID: 15343213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescriptions for category D and X drugs during pregnancy in Taiwan: a population-based study.
    Kao LT; Chen YH; Lin HC; Chung SD
    Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1029-34. PubMed ID: 24578346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of prescription medications with a potential for fetal harm among pregnant women.
    Andrade SE; Raebel MA; Morse AN; Davis RL; Chan KA; Finkelstein JA; Fortman KK; McPhillips H; Roblin D; Smith DH; Yood MU; Platt R; H Gurwitz J
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):546-54. PubMed ID: 16586470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of drug use among pregnant women in Addis Ababa, Ethiopia.
    Kebede B; Gedif T; Getachew A
    Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):462-8. PubMed ID: 19334033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care provider attitudes and practices related to intrauterine devices for nulliparous women.
    Tyler CP; Whiteman MK; Zapata LB; Curtis KM; Hillis SD; Marchbanks PA
    Obstet Gynecol; 2012 Apr; 119(4):762-71. PubMed ID: 22433340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug utilization pattern among pregnant women attending maternal and child health clinic of tertiary hospital in eastern Ethiopia: Consideration of toxicological perspectives.
    Bedewi N; Sisay M; Edessa D
    BMC Res Notes; 2018 Dec; 11(1):858. PubMed ID: 30514377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of medication use during pregnancy in rheumatoid arthritis.
    Kuriya B; Hernández-Díaz S; Liu J; Bermas BL; Daniel G; Solomon DH
    Arthritis Care Res (Hoboken); 2011 May; 63(5):721-8. PubMed ID: 21557526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women.
    Cleary BJ; Butt H; Strawbridge JD; Gallagher PJ; Fahey T; Murphy DJ
    Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):408-17. PubMed ID: 20099251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethnic differences in drug utilization pattern during pregnancy: a cross-sectional study.
    Baraka MA; Steurbaut S; Coomans D; Dupont AG
    J Matern Fetal Neonatal Med; 2013 Jun; 26(9):900-7. PubMed ID: 23350574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge transfer and translation: examining how teratogen information is disseminated.
    Shahin I; Einarson A
    Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):956-61. PubMed ID: 21948595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent changes in pregnancy and lactation labeling: retirement of risk categories.
    Ramoz LL; Patel-Shori NM
    Pharmacotherapy; 2014; 34(4):389-95. PubMed ID: 24390829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of medication use during pregnancy in mainland China: based on a national health insurance database in 2015.
    Zhang J; Ung COL; Guan X; Shi L
    BMC Pregnancy Childbirth; 2019 Dec; 19(1):459. PubMed ID: 31795963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.